Xtx Topco LTD Charles River Laboratories International, Inc. Transaction History

Xtx Topco LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$203.52 - $273.43 $247,683 - $332,764	1,217 New	1,217 $329,000
Q3 2023 Nov 13, 2023	BUY	$194.44 - $217.61 $1.06 Million - $1.18 Million	5,426 New	5,426 $1.06 Million
Q1 2023 May 12, 2023	SELL	$191.89 - $259.92 $88,269 - $119,563	-460 Reduced 28.38%	1,161 $234,000
Q4 2022 Feb 14, 2023	BUY	$197.11 - $250.07 $319,515 - $405,363	1,621 New	1,621 $353,000
Q4 2021 Feb 11, 2022	SELL	$351.38 - $448.68 $507,392 - $647,893	-1,444 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$372.64 - $458.3 $538,092 - $661,785	1,444 New	1,444 $596,000
Q2 2021 Aug 12, 2021	SELL	$294.17 - $371.65 $296,817 - $374,994	-1,009 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$249.67 - $299.48 $251,917 - $302,175	1,009 New	1,009 $292,000

698

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.